Gesellschaft für Studienmanagement und Onkologie

Gesellschaft für Studienmanagement und Onkologie (GSO) is a specialized Contract Research Organization (CRO) based in Hamburg, Germany, that focuses on clinical research within the fields of oncology and hematology. Founded in 1998, the company provides a full suite of services for Phase I through Phase IV clinical trials, including project management, clinical monitoring, regulatory affairs, and data management. GSO is particularly noted for its close collaboration with academic study groups and its expertise in navigating the complex regulatory landscape of cancer research in Europe. The organization supports both pharmaceutical industry sponsors and investigator-initiated trials, ensuring high-quality data collection and adherence to international standards. By bridging the gap between clinical practice and drug development, GSO plays a vital role in bringing innovative oncological treatments to market.